CTAD: Multiple Alzheimer’s Vaccines Show Promise in Early Trials
At least nine different vaccines are currently in clinical trials for treating Alzheimer’s disease. While none of these vaccine candidates have started Phase 3…
At least nine different vaccines are currently in clinical trials for treating Alzheimer’s disease. While none of these vaccine candidates have started Phase 3…
At the 16th Annual Clinical Trials in Alzheimer’s Disease (CTAD) this week, T3D Therapeutics shared early data on an experimental Alzheimer’s pill they’re calling…
Since launching Being Patient, I’ve spoken with and interviewed many people who are just beginning to lose their memory. If it is something more…
For people living with dementia and their caregivers, the term Mild Cognitive Impairment (MCI) may be familiar. Often the first diagnosis many patients receive,…
Alzheimer’s disease is responsible for 60 to 80 percent of all cases of dementia, and to date, most dementia research and treatments have focused…